Infertility. Female infertility, unspecified
Conditions
Interventions
if <10 ng/mL, 400 mg/day progesterone is administered.
Intervention 1: Estradiol valerate is initiated at 4 mg/day on day 2 of the menstrual cycle and is adjusted to 8 mg/day based on endometrial thickness. Once the endometrial thickness reaches =8 mm, pr
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 42 Years
Inclusion criteria
Inclusion criteria: Regular menstrual cycle Normal intrauterine cavity on pretreatment assessment BMI less than or equal to 30 No evidence of endometriosis grade 3 or highe No evidence of ovulation disorder.
Exclusion criteria
Exclusion criteria: Failure of embryo thawing Patient's refusal to continue treatment Failure of dominant follicle growth Lack of suitable endometrium
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy: positive ß-HCG test greater than 25 mIU/ml after 12–16 days from embryo transfer. Timepoint: 12–16 days after embryo transfer. Method of measurement: Blood test.;Clinical pregnancy rate. Timepoint: 6 weeks after transfer. Method of measurement: Ultrasound examination.;Ongoing Pregnancy Rate. Timepoint: At 20 weeks after embryo transfer. Method of measurement: Ultrasound examination.;Miscarriage rate. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Ultrasound examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMalihe Mahmoudinia
Mashhad University of Medical Sciences
Outcome results
None listed